当前位置：首页 SCI 期刊医学 Signal Transduction And Targeted Therapy(非官网)

Signal Transduction And Targeted TherapySCIE

国际简称：SIGNAL TRANSDUCT TAR 参考译名：信号转导与靶向治疗

中科院分区
1区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：2095-9907; E-ISSN：2059-3635; 是否OA：开放; 是否预警：否; TOP期刊：是

出版信息：: 出版地区：United Kingdom; 出版商：Springer Nature; 出版语言：English; 出版周期：1 issue/year; 出版年份：2016; 研究方向：Biochemistry, Genetics and Molecular Biology-Genetics

评价信息：: 影响因子：40.8; CiteScore指数：44.5; SJR指数：8.737; SNIP指数：5.308

发文数据：: Gold OA文章占比：99.57%; 研究类文章占比：60.29%; 年发文量：272; 自引率：0.0152...; 开源占比：1; 出版撤稿占比：0; 出版国人文章占比：0.61; OA被引用占比：1

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Signal Transduction And Targeted Therapy期刊介绍

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.

期刊简介Signal Transduction And Targeted Therapy期刊介绍

《Signal Transduction And Targeted Therapy》自2016出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 5 Weeks
国际TOP期刊
医学
BIOCHEMISTRY & MOLECULAR BIOLOGY
SCIE
中科院1区
非预警

Cite Score数据（2024年最新版）Signal Transduction And Targeted Therapy Cite Score数据

CiteScore：44.5
SJR：8.737
SNIP：5.308

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Genetics	Q1	2 / 347	99%
大类：Biochemistry, Genetics and Molecular Biology 小类：Cancer Research	Q1	5 / 230	98%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Signal Transduction And Targeted Therapy 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：是

大类学科	分区	小类学科	分区
医学	1区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学	1区 1区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Signal Transduction And Targeted Therapy JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	3 / 313	99.2%
学科：CELL BIOLOGY	SCIE	Q1	5 / 205	97.8%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	5 / 313	98.56%
学科：CELL BIOLOGY	SCIE	Q1	6 / 205	97.32%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND320
USA96
England14
GERMANY (FED REP GER)12
Canada10
Australia8
Japan6
Spain6
India5
France4

本刊中国学者近年发表论文

1、Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
Author: Wang, Qian; Yang, Chenchen; Yin, Li; Sun, Jing; Wang, Wei; Li, Hengchun; Zhang, Zhengyuan; Chen, Si; Liu, Bo; Liu, Zijian; Shi, Linjing; Liu, Xiaolin; Guan, Suhua; Wang, Chunhua; Qu, Linbing; Feng, Ying; Niu, Xuefeng; Feng, Liqiang; Zhao, Jincun; Li, Pingchao; Chen, Ling; Zhong, Nanshan

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01423-6
2、Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
Author: Hu, Junhui; Tan, Ping; Ishihara, Moe; Bayley, Nicholas A.; Schokrpur, Shiruyeh; Reynoso, Jeremy G.; Zhang, Yangjun; Lim, Raymond J.; Dumitras, Camelia; Yang, Lu; Dubinett, Steven M.; Jat, Parmjit S.; Van Snick, Jacques; Huang, Jiaoti; Chin, Arnold I.; Prins, Robert M.; Graeber, Thomas G.; Xu, Hua; Wu, Lily

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01362-2
3、Combination therapy with saxagliptin and vitamin D for the preservation of beta-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial
Author: Yan, Xiang; Li, Xia; Liu, Bingwen; Huang, Jiaqi; Xiang, Yufei; Hu, Yuhang; Tang, Xiaohan; Zhang, Ziwei; Huang, Gan; Xie, Zhiguo; Zhou, Houde; Liu, Zhenqi; Wang, Xiangbing; Leslie, Richard David; Zhou, Zhiguang

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01369-9
4、Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Author: Ma, Jun; Li, Yanan; Yang, Xiangyu; Liu, Kai; Zhang, Xin; Zuo, Xianghao; Ye, Runyu; Wang, Ziqiong; Shi, Rufeng; Meng, Qingtao; Chen, Xiaoping

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01430-7
5、RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis
Author: Chen, Lei; Zhang, Wenjing; Chen, Dan; Yang, Quan; Sun, Siwen; Dai, Zhenwei; Li, Zhengzheng; Liang, Xuemei; Chen, Chaoqun; Jiao, Yuexia; Zhi, Lili; Zhao, Lianmei; Zhang, Jinrui; Liu, Xuefeng; Zhao, Jinyao; Li, Man; Wang, Yang; Qi, Yangfan

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01367-x
6、Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2
Author: Xu, Zhijian; Shi, Danrong; Han, Jian-Bao; Ling, Yun; Jiang, Xiangrui; Lu, Xiangyun; Li, Chuan; Gong, Likun; Ge, Guangbo; Zhang, Yani; Zang, Yi; Song, Tian-Zhang; Feng, Xiao-Li; Tian, Ren-Rong; Ji, Jia; Zhu, Miaojin; Wu, Nanping; Wu, Chunhui; Wang, Zhen; Xu, Yechun; Peng, Cheng; Zheng, Min; Yang, Junling; Du, Feifei; Wu, Junliang; Wang, Peipei; Shen, Jingshan; Zhang, Jianliang; Zheng, Yong-Tang; Yao, Hangping; Zhu, Weiliang

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01429-0
7、Targeting integrin pathways: mechanisms and advances in therapy
Author: Pang, Xiaocong; He, Xu; Qiu, Zhiwei; Zhang, Hanxu; Xie, Ran; Liu, Zhiyan; Gu, Yanlun; Zhao, Nan; Xiang, Qian; Cui, Yimin

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-022-01259-6
8、SCGN deficiency is a risk factor for autism spectrum disorder
Author: Liu, Zhe; Tan, Shuai; Zhou, Lianyu; Chen, Li; Liu, Mingfeng; Wang, Wang; Tang, Yingying; Yang, Qin; Chi, Sensen; Jiang, Peiyan; Zhang, Yue; Cui, Yonghua; Qin, Junhong; Hu, Xiao; Li, Shenglong; Liu, Qi; Chen, Lu; Li, Song; Burstein, Ezra; Li, Wei; Zhang, Xiaohu; Mo, Xianming; Jia, Da

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-022-01225-2